Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis.
about
Anticancer efficacy of a supramolecular complex of a 2-diethylaminoethyl-dextran-MMA graft copolymer and paclitaxel used as an artificial enzymeSelection of Reference Genes for Expression Study in Pulp and Seeds of Theobroma grandiflorum (Willd. ex Spreng.) Schum.Microtubule drugs: action, selectivity, and resistance across the kingdoms of life.An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
P2860
Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rationalization of paclitaxel ...... principal component analysis.
@ast
Rationalization of paclitaxel ...... principal component analysis.
@en
Rationalization of paclitaxel ...... principal component analysis.
@nl
type
label
Rationalization of paclitaxel ...... principal component analysis.
@ast
Rationalization of paclitaxel ...... principal component analysis.
@en
Rationalization of paclitaxel ...... principal component analysis.
@nl
prefLabel
Rationalization of paclitaxel ...... principal component analysis.
@ast
Rationalization of paclitaxel ...... principal component analysis.
@en
Rationalization of paclitaxel ...... principal component analysis.
@nl
P2093
P2860
P356
P1433
P1476
Rationalization of paclitaxel ...... principal component analysis.
@en
P2093
Bhabatarak Bhattacharya
Gautam Basu
Lalita Das
P2860
P2888
P356
10.1186/1756-0500-5-395
P577
2012-08-01T00:00:00Z
P5875
P6179
1010054970